Achieve Life Sciences, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ACHV on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
22722 29 Th Dr. Se, Suite 100, Seattle, WA

Insiders trading volume in the past year

Achieve Life Sciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dialectic Capital Management, Lp 10%+ Owner $19.5M Nov 18, 2022
Thomas B. King Director $2.54M -$387K -13.2% Sep 4, 2025
Richard Stewart Chief Executive Officer, Director $1.25M -$350K -21.8% Sep 18, 2025
K. Oki Chief Financial Officer $990K -$117K -10.6% Sep 18, 2025
Cindy Jacobs President & CMO $797K -$76.5K -8.76% Sep 4, 2025
Jaime Xinos Chief Commercial Officer $573K -$57.8K -9.16% Sep 4, 2025
John Bencich CEO, Director $369K Aug 16, 2024
Jerry Wan Principal Accounting Officer $267K -$39K -12.7% Sep 4, 2025
Craig Donnelly Chief Operations Officer $165K Oct 1, 2025
Anthony Clarke Cso $39.5K Apr 28, 2022
Donald Joseph Director May 31, 2022
Bridget Martell Director Jun 6, 2025
Kristen B. Slaoui Director Jun 6, 2025
Jay M. Moyes Director May 31, 2022
Martin A. Mattingly Director May 31, 2022
Nancy R. Phelan Director Jun 6, 2025
Thomas Sellig Director Jun 6, 2025
Vaughn Himes Director Jan 22, 2024
Erik Atkisson Chief Legal Officer Oct 20, 2025
Stuart Duty Director Jun 6, 2025
Svb Financial Group 10%+ Owner Nov 18, 2022

Recent Insider Transactions by Companies or Individuals for Achieve Life Sciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.